HUN 241220 23.00P (HUN241220P23000) Stock Options, News & Quotes

US OptionsDetailed Quotes

HUN241220P23000

Watchlist

2.70
0.000.00%

15min DelayClose Dec 20 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

RBC Capital Maintains Huntsman(HUN.US) With Hold Rating, Cuts Target Price to $20
Moomoo NewsDec 20 13:31 ET · Ratings
Huntsman Price Target Lowered to $20 From $23 at RBC Capital
Yahoo FinanceDec 20 07:36 ET
Huntsman Is Maintained at Sector Perform by RBC Capital
Dow JonesDec 19 12:25 ET · Ratings
RBC Capital Maintains Sector Perform on Huntsman, Lowers Price Target to $20
BenzingaDec 19 12:15 ET · Ratings
Beyond The Numbers: 4 Analysts Discuss Huntsman Stock
BenzingaDec 18 14:00 ET
Huntsman Is Maintained at Neutral by Citigroup
Dow JonesDec 18 11:03 ET · Ratings

Comments

Moomoo AI

Jan 7 06:30

Despite low growth, undervalued Huntsman shares might be a good investment. However, the company's financial health is also key to consider. Its future outlook is possibly not fully reflected yet, offering a potentially attractive opportunity.

Should You Investigate Huntsman Corporation (NYSE:HUN) At US$24.82?

Moomoo AI

Dec 18, 2023 09:51

Huntsman's low P/S ratio is down to limited revenue growth predictions. Failure to increase its revenue might keep its share price low and possibly lower P/S levels.

Huntsman Corporation's (NYSE:HUN) Revenues Are Not Doing Enough For Some Investors

Moomoo AI

Nov 27, 2023 09:37

Huntsman's stagnant business growth, marked by a declining ROCE and stable capital employed, dampens its investment appeal despite a robust 43% stock return over five years.

Huntsman (NYSE:HUN) Will Be Looking To Turn Around Its Returns

Moomoo Breakfast US

Sep 16, 2022 07:31

Columns Today's Pre-Market Stock Movers: FDX, UBER, GE, NTLA and More

Gapping up
In reaction to earnings/guidance:
• $Bowlero (BOWL.US)$ +3.4%
Other news:
• $Intellia Therapeutics (NTLA.US)$ +10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002)
• $Gogo Inc (GOGO.US)$ +5% (Repurchases 1.5 million shares of common stock from BlackRock)
• $ADC Therapeutics (ADCT.US)$ +2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...

Moomoo Breakfast US

Jun 14, 2022 07:28

Columns Today's pre-market stock movers: ORCL, CLR, NOK, GRPN and more

Gainers:
• $National Vision (EYE.US)$ +13.8% (appointed to join S&P SmallCap 600)
• $Braze (BRZE.US)$ +12.2% (In reaction to earnings/guidance)
• $Oracle (ORCL.US)$ +11.7% (In reaction to earnings/guidance)
• $TeraWulf (WULF.US)$ +7.5% (announced recent financing actions and near-term ramp of digital infrastructure)
• $Continental Resources (CLR.US)$ +7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share)
•...